Sort   by:  
 Page size 
UnknownPrimary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus fluoropyrimidines: A propensity score matched analysis.
Not available
S-EPMC9413268 | biostudies-literature
UnknownGlobal real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
Not available
S-EPMC11026312 | biostudies-literature
UnknownAssessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial.
Not available
S-EPMC6440108 | biostudies-literature
UnknownSafety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study.
Not available
S-EPMC10323889 | biostudies-literature
UnknownOff-label use of combined antiretroviral therapy, analysis of data collected by the Italian Register for HIV-1 infection in paediatrics in a large cohort of children.
Not available
S-EPMC8760752 | biostudies-literature
UnknownThe prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The Δ-Meet-URO analysis.
Not available
S-EPMC9541611 | biostudies-literature
UnknownLong-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world.
Not available
S-EPMC12276448 | biostudies-literature
UnknownConsensus statement on mesotherapy for clinical and regulatory practice.
Not available
S-EPMC12864338 | biostudies-literature
UnknownDiagnosis, treatment and prevention of pediatric obesity: consensus position statement of the Italian Society for Pediatric Endocrinology and Diabetology and the Italian Society of Pediatrics.
Not available
S-EPMC6069785 | biostudies-literature
UnknownDistinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.
Not available
S-EPMC7027476 | biostudies-literature
Sort   by:  
 Page size